Insider filing · REGN
Andrew J Murphy
Co-Chief Scientific Officer
profile →
Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · 35 filings in 24 months
ticker →
Andrew J Murphy sold $2.6M of Regeneron Pharmaceuticals (REGN)
Executed Oct 14, disclosed Oct 15, 1 day later.
Value, as filed
$2.6M
3,352 sh across 11 lots
Executed
Oct 14
the trade date, as filed
Disclosed
Oct 15
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AMAndrew J Murphy (Co-Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $2.6M of REGN (3,352 sh across 11 lots, as filed), executed Oct 14.
The name
REGNHealthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→